Literature DB >> 34774489

Assessment of retinal oxygen metabolism, visual function, thickness and degeneration markers after variable ischemia/reperfusion in rats.

Nathanael Matei1, Sophie Leahy1, Norman P Blair2, Mahnaz Shahidi3.   

Abstract

After total retinal ischemia induced experimentally by ophthalmic vessel occlusion followed by reperfusion, studies have reported alterations in retinal oxygen metabolism (MO2), delivery (DO2), and extraction fraction (OEF), as well as visual dysfunction and cell loss. In the current study, under variable durations of ischemia/reperfusion, changes in these oxygen metrics, visual function, retinal thickness, and degeneration markers (gliosis and apoptosis) were assessed and related. Additionally, the prognostic value of MO2 for predicting visual function and retinal thickness outcomes was reported. Sixty-one rats were divided into 5 groups of ischemia duration (0 [sham], 60, 90, 120, or 180 min) and 2 reperfusion durations (1 h, 7 days). Phosphorescence lifetime and blood flow imaging, electroretinography, and optical coherence tomography were performed. MO2 reduction was related to visual dysfunction, retinal thinning, increased gliosis and apoptosis after 7-days reperfusion. Impairment in MO2 after 1-h reperfusion predicted visual function and retinal thickness outcomes after 7-days reperfusion. Since MO2 can be measured in humans, findings from analogous studies may find value in the clinical setting.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ophthalmic vessel occlusion; Retinal ischemia; Retinal oxygen metabolism

Mesh:

Substances:

Year:  2021        PMID: 34774489      PMCID: PMC8665131          DOI: 10.1016/j.exer.2021.108838

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  78 in total

1.  Delayed recanalization at 3 days after permanent MCAO attenuates neuronal apoptosis through FGF21/FGFR1/PI3K/Caspase-3 pathway in rats.

Authors:  Wen Zheng; Nathanael Matei; Jinwei Pang; Xu Luo; Zhi Song; Jiping Tang; John H Zhang
Journal:  Exp Neurol       Date:  2019-07-08       Impact factor: 5.330

2.  Significance of outer blood-retina barrier breakdown in diabetes and ischemia.

Authors:  Hui-Zhuo Xu; Yun-Zheng Le
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-05       Impact factor: 4.799

Review 3.  Oxygen in health and disease: regulation of oxygen homeostasis--clinical implications.

Authors:  Emin Maltepe; Ola Didrik Saugstad
Journal:  Pediatr Res       Date:  2009-03       Impact factor: 3.756

4.  Progressive impairment of brain oxidative metabolism reversed by reperfusion following middle cerebral artery occlusion in anaesthetized baboons.

Authors:  O Touzani; A R Young; J M Derlon; J C Baron; E T MacKenzie
Journal:  Brain Res       Date:  1997-08-29       Impact factor: 3.252

Review 5.  Retinal oxygen distribution. Its role in the physiopathology of vasoproliferative microangiopathies.

Authors:  C J Pournaras
Journal:  Retina       Date:  1995       Impact factor: 4.256

Review 6.  Cerebral perfusion and stroke.

Authors:  H S Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

7.  A paired comparison of two models of experimental retinal ischemia.

Authors:  P L Gehlbach; R L Purple
Journal:  Curr Eye Res       Date:  1994-08       Impact factor: 2.424

8.  Loss of inner retinal neurons after retinal ischemia in rats.

Authors:  Heiko Schmid; Marina Renner; H Burkhard Dick; Stephanie C Joachim
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-28       Impact factor: 4.799

9.  Liposome-delivered ATP effectively protects the retina against ischemia-reperfusion injury.

Authors:  Galina Dvoriantchikova; David J Barakat; Eleut Hernandez; Valery I Shestopalov; Dmitry Ivanov
Journal:  Mol Vis       Date:  2010-12-28       Impact factor: 2.367

10.  Dysfunctional regulation of ocular blood flow: A risk factor for glaucoma?

Authors:  Danny Moore; Alon Harris; Darrell Wudunn; Nisha Kheradiya; Brent Siesky
Journal:  Clin Ophthalmol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.